Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management ChangeIRVINE, CA, and HERSTAL, BELGIUM – July 3, 2025 (GlobeNewswire) – MDxHealth SA (
NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced the appointment of Michael Holder to its Board of Directors as the Chair of the Audit Committee. Mr. Holder will take the seat of Regine Slagmulder, whose term completed in May.
MDxHealth Reports Q1-2025 ResultsYear-over-year Q1 revenues increase by 22% to $24.3 million71% year-over-year improvement in adjusted EBITDA in first quarterConference call with Q&A today at 4:30 PM ET / 22:30 CET
Mdxhealth Announces Fourth Quarter and Full-Year 2024 Financial ResultsFourth quarter revenue growth of 28% to $24.7 million2024 revenue growth of 28% to $90.0 million68% improvement in adjusted EBITDA in fourth quarterConference call with Q&A today at 4:30 PM EST / 22:30 CET
MDxHealth to Participate in Piper Sandler Healthcare ConferenceMDxHealth to Participate in Piper Sandler Healthcare Conference
MDxHealth Announces Pricing of Offering of Ordinary SharesMDxHealth Announces Pricing of Offering of Ordinary Shares
MDxHealth Announces Launch of Offering of Ordinary SharesMDxHealth Announces Launch of Offering of Ordinary Shares
MDxHealth Reports Q2 and Half Year 2024 ResultsMDxHealth Reports Q2 and Half Year 2024 Results
MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMedMDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer OfferingMdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering
Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial ResultsMdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results
Mdxhealth Announces Resignation of Board MemberMdxhealth Announces Resignation of Board Member
MDxHealth Announces Completion of Transition to Single Listing on NasdaqNEWS RELEASE – REGULATED INFORMATIONDECEMBER 18, 2023, 1:00 AM ET / 07:00 AM CET
Mdxhealth's New Share Capital Amount and New Number of Shares NEWS RELEASE - REGULATED INFORMATIONOctober 20, 2023, 4:00 PM EDT / 22:00 CET
MDxHealth Reports Preliminary Q3-2023 RevenuesNEWS RELEASE – INSIDE AND REGULATED INFORMATION9 OCTOBER 2023, 4PM ET / 22:00 CET
MDxHealth Reports Q2 and Half Year 2023 ResultsNEWS RELEASE – REGULATED INFORMATION23 AUGUST 2023, 4:00PM EDT / 22:00 CET
MDxHealth Reports Q1-2023 ResultsNEWS RELEASE - REGULATED INFORMATION15 MAY 2023, 4:00PM EDT / 22:00 CET
Foundational LCD Covers Select mdx for Prostate CancerNEWS RELEASE – INSIDE INFORMATIONApril 19, 2023, 4:00PM EDT / 22:00 CET
MDxHealth Shareholder Transparency DeclarationNEWS RELEASE – REGULATED INFORMATION APRIL 7, 2023, 4:30 pm ET/ 22:30 CET
MDxHealth Announces Update of Outstanding Shares and Voting RightsNEWS RELEASE – REGULATED INFORMATIONMARCH 8, 2023, 5:00 pm ET/ 23:00 CET
MDxHealth Shareholder Transparency DeclarationsNEWS RELEASE – REGULATED INFORMATION MARCH 3, 2023, 4:30 pm ET/ 22:30 CET
MDxHealth Shareholder Transparency DeclarationNEWS RELEASE – REGULATED INFORMATIONFEBRUARY 21, 2023, 4:30 pm ET/ 22:30 CET
MDxHealth Announces Pricing of Offering of ADSs in the United StatesNEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONFEBRUARY 3, 2023, 8:00 am ET/ 14:00 CET
MDxHealth Announces Launch of Offering of ADSs in the United StatesNEWS RELEASE – REGULATED INFORMATIONINSIDE INFORMATIONFEBRUARY 1, 2023, 4PM ET/ 22:00 CET
MDxHealth Reports Preliminary 2022 Revenues and Reaffirms 2023 Revenue GuidanceNEWS RELEASE – INSIDE AND REGULATED INFORMATION9 JANUARY 2023, 4PM ET / 22:00 CET
MDxHealth Provides Business UpdateNEWS RELEASE – INSIDE AND REGULATED INFORMATION29 NOVEMBER 2022, 4:00PM EDT / 22:00 CET
MDxHealth Reports Q3-2022 ResultsNEWS RELEASE - REGULATED INFORMATION27 OCTOBER 2022, 4:00PM EDT / 22:00 CET
